Remove Insurance Remove Patient Advocacy Remove Patient Centered Care
article thumbnail

Why the FTC Investigated PBMs and What it Means for You

ACMA Blog

Given the current state of PBM dominance, pharmacists, health insurers, and drug manufacturers often have little choice but to interact with the large, dominant PBMs when distributing certain drugs. PBMs may also use narrow networks to channel patients into their own affiliated pharmacies, even if competitors offer drugs at the same prices.